Results 51 to 60 of about 6,744 (217)
Treatment of Crimean-Congo hemorrhagic fever
, 2007 Ribavirin is a synthetic purine nucleoside analog with a modified base and D-ribose sugar, also known as virazol, first synthesized by Sidwell and colleagues in 1972 [43, 49] (Fig. 19-1).
core +1 more source
Crimean-Congo Hemorrhagic Fever Virus in Ticks from Migratory Birds, Morocco
Emerging Infectious Diseases, 2013 Crimean-Congo hemorrhagic fever virus was detected in ticks removed from migratory birds in Morocco. This finding demonstrates the circulation of this virus in northwestern Africa and supports the hypothesis that the virus can be introduced into Europe ...
Ana M. Palomar +8 more
doaj +1 more source
, 2010 Expert opinion was elicited to undertake a qualitative risk assessment to estimate the current and future risks to the European Union (EU) from five vector-borne viruses listed by the World Organization for Animal Health.
Gale, P.F. +10 more
core +1 more source
Medical and Veterinary Entomology, EarlyView.Amblyomma sculptum showed a plasmatocyte‐dominant haemocyte profile. Beauveria bassiana increased plasmatocytes and reduced granulocytes, whereas Metarhizium robertsii did not cause significant changes. Amblyomma americanum showed a granulocyte‐dominant haemocyte profile. Beauveria bassiana reduced total haemocytes and granulocytes. B.
Cárita de Souza Ribeiro‐Silva +7 more
wiley +1 more source
Seroprevalence of Crimean-Congo Hemorrhagic Fever Virus, Bulgaria
Emerging Infectious Diseases, 2013 To the Editor: Crimean-Congo hemorrhagic fever (CCHF) is endemic in southern Russia, southeastern Europe, Africa, the Middle East, and southwestern Asia (1). The incidence and spread of the disease have increased in recent years. In Bulgaria, located on the Balkan Peninsula, CCHF is endemic.
Christova, Iva +5 more
openaire +3 more sources
Crimean-Congo Hemorrhagic Fever in Bulgaria
Emerging Infectious Diseases, 2004 We report the epidemiologic characteristics of Crimean-Congo hemorrhagic fever in Bulgaria, as well as the first genetic characterization of the virus strains circulating in the country in 2002–2003 that caused disease in humans.
Anna Papa +3 more
doaj +1 more source
Zoonoses and Public Health, EarlyView.ABSTRACT Introduction Crimean‐Congo haemorrhagic fever virus (CCHFV) is a tick‐borne zoonotic pathogen of major public health importance in Africa. Although CCHFV exposure has been reported in several livestock species in Nigeria, data on equids remain limited despite their extensive involvement in livestock movement and trade.
David O. Ehizibolo +14 more
wiley +1 more source
Recent advances in understanding Crimean–Congo hemorrhagic fever virus [PDF]
F1000Research, 2018 Crimean-Congo hemorrhagic fever virus (CCHFV) is a widely distributed hemorrhagic fever virus and the cause of hemorrhagic disease in Africa, Southern and Eastern Europe, the Middle East, India and Asia. Recent emergence of CCHFV into Spain indicates that the geographic range of this virus is expanding and the presence of its tick vector in several ...
David W. Hawman, Heinz Feldmann
openaire +2 more sources
Estimates and prevention of Crimean-Congo hemorrhagic fever risks for health-care workers
, 2007 Crimean-Congo hemorrhagic fever virus (CCHFV) is one of the most widespread pathogens causing viral hemorrhagic fever (VHF). A disease with the clinical and epidemiological features of Crimean-Congo hemorrhagic fever (CCHF) has been long known in Central
core +1 more source
Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1650-1661, June 2026.AGILE (NCT04746183) is a Phase Ib/IIa platform, evaluating candidates to treat COVID‐19. Candidate Specific Trial 6 evaluated the safety and optimal dose of a novel intravenous formulation of favipiravir in a dose‐escalating, open‐label, randomized, controlled, Bayesian adaptive Phase Ib trial.
Tim Rowland +48 more
wiley +1 more source